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1. Introduction 
In 1931 Von Euler and Gaddum discovered sub- 
stance P (SP) in crude acid alcohol extracts of equine 
brain and intestine [I]. It was then isolated from 
bovine hypothalamus [2,3]. SP was determined as an 
undecapeptide as two others peptides, eledoisin and 
physalaemin which exhibit similar pharmacological 
properties [4]. The proposed structure: 
Arg-Pro-Lys-Pro-Gln-Gln-Phe- 
Phe-Gly-Leu-Met-NH2 
was confirmed by numerous syntheses [4-71. With 
the development of immunohistochemistry [8] and 
the use of biochemical approaches [9,10], SP was 
found to be localized in numerous peripheral and 
central neurons. SP could act as a neurotransmitter or 
a neuromodulator [I l-151. However, little is known 
concerning its biosynthesis and its enzymatic inactiva- 
tion. Moreover only a few binding studies have been 
made to characterize the SP receptor(s). This 
prompted us to synthetize a tritiated SP retaining all 
its chemical and biological potencies. Since SP does 
not contain residues such as tyrosine or histidine 
which can easily be labelled [ 16,171 and as the 
analogue Tyr-8-SP is less potent, direct catalytic 
tritium exchange was investigated [18]. In addition, 
this report describes labelling of SP and Nle SP (Arg- 
Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Lcu-Nle) 
(NH,) by catalytic deshalogenation of their Phe 
(p-C1)7~8 derivatives. Nle-SP has recently been 
shown to possess a high biological activity [ 191 and 
in contrast to methionine SP, is not as sensitive to 
oxidizing reagents. The ‘H-labelling by exchange or 
by deshalogenation yielded products with specific 
radioactivities of 15-50 Ci/mmole, respectively. 
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2. Materials and methods 
2.1. Materials 
Substance P and Phe (p-C1)7,8 substance P were 
purchased from Penninsula Labs (Mallet) and Phe- 
(p-Cl)7>8 Nle-SP waSa generous gift from Dr M. Bienert 
and P. Oehme (Institut fiir Wirkstofforschung, 
Akademie der Wissenschaften der DDR, Berlin). The 
final 3H-derivatives were purified by thin-layer 
chromatography (TLC) on silicagel (Merck 11845) or 
cellulose plates (Merck 57 16) and by HPLC (Waters: 
pump 6000, injector U6K and UV detector 440). 
The catalysts Pd/A1203 (10%) and Pd/C were supplied 
by Engelhard (Rome). Tritium gas was made by CEA, 
Saclay. 3H-scanning of TLC plates was performed 
with a Berthold Scanner II (FRG). 
Albino male guinea pigs (-300 g), starved for 
24 h were used for bioassays. Immunochemical reac- 
tivities of [3H]SP and 3H-analogues were measured 
with SP antibodies prepared by P. Pradelles [20] 
using a modification of the method in [2 11. 
2.2. Tritiation methods 
SP or analogues (0.5-I pmol) were dissolved in 
1 ml Na-phosphate buffer (0.1 M, pH 7) and solutions 
frozen. The catalyst (lo-20 mg Pd/Al,O,) was then 
added and the reacting vial was connected to the 
tritium supplying automatic apparatus [22]. At 
10m4 Torr, pure tritium gas (30-40 C) was introduced 
and compressed until 700-750 Torr. After thawing 
the reaction mixture was kept at 20°C and magneti- 
cally stirred for 20 min. The absorption of tritium 
gas produced a reduction of pressure of -80-l 00 
Torr. The catalyst was separated from the reacting 
solution by filtration over Millipore (Mitex, LSWP 
01300) and labile tritium was eliminated by successive 
flash evaporations in dilute acetic acid (l%, v/v). 
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2.3. 3H-I~abelling by catalytic deshalogenation 
The procedure selected was similar to that above 
except for the nature and amount of the catalyst used. 
We have observed that the Pd/Charcoal catalyst used 
at concentrations slightly higher (40-50 mg) than for 
the tritiation method by exchange was less poisoned 
by halogen ions formed during the reaction. 
3. Results 
3.1. Analytical identification of (3H]SP and of 
/ 3H]Nle+SP 
The first attempts to purify the [3H]SP reaction 
mixtures were performed using TLC on cellulose, 
with n-butanol:acetic acid:water, 75: lo:25 (v/v/v) as 
the eluent (4”C, elution time 8 h). The radiogram 
(autoradiography or scanning) revealed a main peak 
(RF 0.42) comigrating with authentic SP and 
corresponding to the spot detectable with ninhydrin. 
In addition, 3 minor peaks (RF 0.21,0.59,0.77) 
were seen. Although this procedure was analytically 
satisfactory the yield of peptide extraction by organic 
solvents from the cellulose layer was quite low and 
oxidation of the methionine residue could not be 
avoided. Amino acid analysis reflected the expected 
formula except from the methionine residue destroyed 
during hydrolysis. These drawbacks were overcome 
using high pressure liquid chromatography (HPLC) 
(p Cl8 Bondapak column, 1 ml/min, methanol:water: 
N ammonium acetate, 1850: 1350:30 (v/v/v) reten- 
tion volume of authentic SP, 8 ml). Under these con- 
ditions SP oxidation was prevented. The labelled SP 
could be stored for 3 months in liquid nitrogen 
without appreciable degradation. 
3.2. Biological tests. Contraction of the isolated 
guinea pig ileum 
The isolated organ was suspended in an oxygenated 
tyrode solution (30 ml) at 37°C containing per ml: 
0.1 pg atropine, 1 .O ,ug mepyramine and 0.1 pug 
methysergide. 
Synthetic SP or Nle-SP were used as standards in a 
cumulative-dose assay [23,24]. The tritiated com- 
pounds behave exactly as authentic SP and Nle-SP 
(fig.1). 
3.3. Radioimmunoassaw (RIA) 
RIA were performed as in [20] with a rabbit anti- 
serum produced by coupling synthetic SP and oval- 
bumine with benzoquinone. The tracer used was 
‘2SI-labelled Tyr-Gly-SP. After incubation (48 h at 
SP 
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Cumulated doses 
Fig.]. Concentration-response curves for SP and 13H]SP tyrode bath 30 ml. SP added in cumulative doses of 15.6 X 10e9 g 
each. [3H]SP solution, 15.4 X IO4 dpm/dose. 
20 
Volume 111, number 1 FEBS LETTERS February 1980 
I I IIll 
6 78910 
I I I I II,,, I I I I w 
20 30 LO5057 100 200 300 500 
Substance P f role/tube 
Fig.2. Radioimmunoassay curve for [SH] SP (o- o) and for synthetic SP as standard (x- x); (m.d. minimum detectable 
amount). 
4°C) of sample (0.1 ml) tracer (0.1 ml, 10 000 dpm) 
and diluted antiserum (0.1 ml, 1: 10 000 final in 
0.02 M phosphate buffer (pH 7.4) 0.5% BSA), the 
reacting mixture was precipitated by adding n-propa- 
no1 (1 ml) and the pellets were then processed for 
y-counting. The minimum detectable amount of SP 
was about 5 fmol and maximum binding was 40% 
with a half displacement observed with 50 fmol syn- 
thetic SP (fig.2). In this assay [‘H]SP of [3H]Nle-SP 
behaved exactly as pure synthetic SP or Nle-SP. 
Nevertheless, it should be pointed out that the anti- 
serum used exhibits an important crossreactivity with 
the C-terminal sequences of SP [20]. Bioassay and 
radioimmunoassays were consistent for the calcula- 
tions of the specific radioactivities of the tritiated 
compounds ( [3H]SP, 15 Ci/mmol and 50 Ci/mmol; 
[3H]Nle-SP, 25 Ci/mmol). * 
4. Discussion 
In the binding study [25] a [3H]SP of 187 Ci/ 
mmol prepared by exchange was used. This technique 
usually leads to compounds of much lower specific 
radioactivities. In fact, in our own conditions SP 
tritiated by catalytic exchange had spec. radioact. 
15 Ci/mmol. Howeve, deshalogenation of the 
dichloro-SP leads to a compound of 50 Ci/mmol 
whereas dichloro-derivative of the Nle analogue 
reached 25 Ci/mmol. A similar specific radioactivity 
for [3H]Nle-SP has also been obtained [26]. In all 
cases indicated by bioassays as well as by radio- 
immunoassays the labelled materials were indistin- 
guishable from the corresponding unlabelled peptides. 
Catalytic exchange of the aromatic protons, despite 
the presence of 2 phenylalanine residues consistently 
leads to lower specific radioactivities when compared 
to the results obtained after tritium substitution of 
an heteroatom. This could result from dilution of 
[3H] SP by cold SP in the exchange procedure or by 
differences in the rates of exchanges of the aromatic 
protons and solvent protons at the surface of the 
catalyst. From our results, catalytic removal of 
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halogenatom affords a convenient route for tritium 
labelling providing that the incorporation of p-chloro 
(or p-bromo) phenylalanine into the peptide is made 
during the peptide synthesis. The specific radioactivi- 
ties of the products prepared should allow studies on 
SP metabolism but unfortunately according to the 
data [Xl, they seem to be too low for the charac- 
terization of the SP receptor(s). 
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